Log in to save to my catalogue

Analysis of Post-Progression Survival in Patients with Unresectable Hepatocellular Carcinoma Treated...

Analysis of Post-Progression Survival in Patients with Unresectable Hepatocellular Carcinoma Treated...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A681210361

Analysis of Post-Progression Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib

About this item

Full title

Analysis of Post-Progression Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib

Publisher

Basel, Switzerland: S. Karger AG

Journal title

Oncology, 2020-11, Vol.98 (11), p.787-797

Language

English

Formats

Publication information

Publisher

Basel, Switzerland: S. Karger AG

More information

Scope and Contents

Contents

Background: Although a strong antitumor effect of lenvatinib (LEN) has been noted for patients with unresectable hepatocellular carcinoma (HCC), there are still no reports on the prognosis for patients with disease progression after first-line LEN therapy. Methods: Patients (n = 141) with unresectable HCC, Child-Pugh class A liver function, and an...

Alternative Titles

Full title

Analysis of Post-Progression Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A681210361

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A681210361

Other Identifiers

ISSN

0030-2414

E-ISSN

1423-0232

DOI

10.1159/000509387

How to access this item